Spatial variations and associated factors of modern contraceptive use in Ethiopia: a spatial and multilevel analysis.
epidemiology
public health
reproductive medicine
statistics & research methods
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
12 10 2020
12 10 2020
Historique:
entrez:
13
10
2020
pubmed:
14
10
2020
medline:
15
5
2021
Statut:
epublish
Résumé
To assess spatial variations in modern contraceptive use and to identify factors associated with it among married women in Ethiopia. Cross-sectional analysis of population-based and health facility data. Ethiopia Demographic and Health Survey data linked to Service Provision Assessment data. 8473 married women and 1020 facilities that reported providing family planning services. A linked secondary data analysis of population and health facility data was carried out. Both multilevel and spatial analyses were conducted to identify key determinants of women's use of modern contraceptive and spatial clustering of modern contraceptive use. Modern contraceptive use. About 24% of the variation in the use of modern contraception was accounted for by location. A one-unit increase in the mean score of health facilities' readiness to provide short-term modern contraceptives in a typical region was associated with a 20-fold increase in the odds of modern contraceptive use (adjusted OR (AOR) 20.49, 95% CI 1.44 to 29.54). In the spatial analysis, it was found that Addis Ababa and the Amhara region had high clusters of modern contraceptive use rates. On the other hand, low rates of contraceptive use were clustered in the Afar and Somali regions. There were significant variations in the use of modern contraceptives across the different regions of Ethiopia. Therefore, regions with low contraceptive rates and high fertility rates should be targeted for scaling up and tailoring of services to the culture and lifestyles of the population of those regions.
Identifiants
pubmed: 33046466
pii: bmjopen-2020-037532
doi: 10.1136/bmjopen-2020-037532
pmc: PMC7552846
doi:
Substances chimiques
Contraceptive Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e037532Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Asia Pac J Public Health. 2010 Oct;22(4):436-50
pubmed: 20659903
Psychol Methods. 2012 Jun;17(2):228-43
pubmed: 22309957
Reprod Health. 2014 Feb 03;11(1):13
pubmed: 24490810
PLoS One. 2017 Nov 13;12(11):e0187311
pubmed: 29131860
Reprod Health. 2013 Sep 26;10:52
pubmed: 24067083
Issues Brief (Alan Guttmacher Inst). 2008 Dec;(5):1-4
pubmed: 19537329
Contracept Reprod Med. 2017 Feb 2;2:10
pubmed: 29201415
Lancet Glob Health. 2018 Apr;6(4):e380-e389
pubmed: 29519649
J Epidemiol Community Health. 2005 Sep;59(9):729-36
pubmed: 16100308
Contracept Reprod Med. 2018 Sep 20;3:12
pubmed: 30250748
Sex Reprod Healthc. 2019 Oct;21:26-32
pubmed: 31395230
BMC Health Serv Res. 2006 Jun 22;6:79
pubmed: 16792810
Lancet. 2006 Nov 18;368(9549):1810-27
pubmed: 17113431
Epidemiol Rev. 2010;32:152-74
pubmed: 20570955
J Epidemiol Community Health. 2006 Apr;60(4):290-7
pubmed: 16537344
BMC Public Health. 2017 Nov 7;17(Suppl 4):775
pubmed: 29143644
PLoS One. 2019 Jul 18;14(7):e0219860
pubmed: 31318939